Platelet-Rich Fibrin in Intraoral Soft Tissue Regeneration
Not Applicable
Withdrawn
- Conditions
- Mucosal Ulceration
- Interventions
- Procedure: Platelet Rich Fibrin Application
- Registration Number
- NCT04022720
- Lead Sponsor
- University of Florida
- Brief Summary
Determine if the use of platelet rich fibrin (PRF) improves the rate and quality of healing for intraoral mucosal and epithelial soft tissue defects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
-
Three categories of patients will be included in this study:
- Osteoradionecrosis (ORN) or medication related osteonecrosis of the jaw (MRONJ) patients who present to clinic with exposed bone and no clinical sign of infection.
- Patients having an excisional biopsy in clinic performed under local anesthesia resulting in a defect that cannot be easily repaired without compromising normal anatomy or function. These situations include excisions which would result in primary closure under tension or with distorted anatomy, require a local flap, or require healing by secondary intention.
- Patients presenting to the post-operative clinic with intraoral surgical wound dehiscence or an intraoral surgical wound healing by secondary intention.
Read More
Exclusion Criteria
- Patients under 18 years of age.
- Patient's unable to participate in blood draw either due to medical compromise, inability to tolerate the procedure, or inability of the physician to successfully draw the blood at the time of appointment.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Platelet Rich Fibrin (PRF) Group Platelet Rich Fibrin Application Patients randomized to this group will receive treatment with a PRF graft.
- Primary Outcome Measures
Name Time Method Change in rate of healing in intraoral mucosa and epithelium soft tissues 3 months post-operatively Improved healing times of PRF patients compared to control group.
- Secondary Outcome Measures
Name Time Method